Display options
Cite
Parolari A, Poggio P, Myasoedova V, et al. Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?. Front Cardiovasc Med. 2016;2:39doi: 10.3389/fcvm.2015.00039.
Parolari, A., Poggio, P., Myasoedova, V., Songia, P., Bonalumi, G., Pilozzi, A., Pacini, D., Alamanni, F., & Tremoli, E. (2015). Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?. Frontiers in cardiovascular medicine, 239. https://doi.org/10.3389/fcvm.2015.00039
Parolari, Alessandro, et al. "Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?." Frontiers in cardiovascular medicine vol. 2 (2015): 39. doi: https://doi.org/10.3389/fcvm.2015.00039
Parolari A, Poggio P, Myasoedova V, Songia P, Bonalumi G, Pilozzi A, Pacini D, Alamanni F, Tremoli E. Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?. Front Cardiovasc Med. 2016 Jan 05;2:39. doi: 10.3389/fcvm.2015.00039. eCollection 2015. PMID: 26779491; PMCID: PMC4700141.
Copy Download .nbib Format: NLM
Share it on

Front Cardiovasc Med. 2016 Jan 05;2:39. doi: 10.3389/fcvm.2015.00039. eCollection 2015.

Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?.

Frontiers in cardiovascular medicine

Alessandro Parolari, Paolo Poggio, Veronika Myasoedova, Paola Songia, Giorgia Bonalumi, Alberto Pilozzi, Davide Pacini, Francesco Alamanni, Elena Tremoli

Affiliations

  1. Dipartimento di Scienze Biomediche per la Salute, Università Degli Studi di Milano, Milan, Italy; Unità Operativa di Cardiochirurgia e Ricerca Traslazionale, San Donato IRCCS, San Donato Milanese, Milan, Italy.
  2. Centro Cardiologico Monzino IRCCS , Milan , Italy.
  3. Centro Cardiologico Monzino IRCCS, Milan, Italy; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università Degli Studi di Milano, Milan, Italy.
  4. Sezione Cardiovascolare, Dipartimento di Scienze Cliniche e di Comunità, Università Degli Studi di Milano , Milan , Italy.
  5. S.Orsola-Malpighi, Dipartimento di Cardiochirurgia, Università di Bologna , Bologna , Italy.
  6. Centro Cardiologico Monzino IRCCS, Milan, Italy; Sezione Cardiovascolare, Dipartimento di Scienze Cliniche e di Comunità, Università Degli Studi di Milano, Milan, Italy.

PMID: 26779491 PMCID: PMC4700141 DOI: 10.3389/fcvm.2015.00039

Abstract

Coronary artery bypass surgery (CABG) is still one of the most frequently performed surgical procedures all over the world. The results of this procedure have been constantly improved over the years with low perioperative mortality rates, with relatively low complication rates. To further improve these outstanding results, the clinicians focused their attention at biomarkers as outcome predictors. Although biological testing for disease prediction has already been discussed many times, the role of biomarkers in outcome prediction after CABG is still controversial. In this article, we reviewed the current knowledge regarding the role of genetic and dynamic biomarkers and their possible association with the occurrence of adverse clinical outcomes after CABG. We also took into consideration that the molecular pathway activation and the possible imbalance may affect hard outcomes and graft patency. We analyzed biomarkers classified in two different categories depending on their possibility to change over time: genetic markers and dynamic markers. Moreover, we evaluated these markers by dividing them, into sub-categories, such as inflammation, hemostasis, renin-angiotensin, endothelial function, and other pathways. We showed that biomarkers might be associated with unfavorable outcomes after surgery, and in some cases improved outcome prediction. However, the identification of a specific panel of biomarkers or of some algorithms including biomarkers is still in an early developmental phase. Finally, larger studies are needed to analyze broad panel of biomarkers with the specific aim to evaluate the prediction of hard outcomes and graft patency.

Keywords: biomarkers; coronary artery bypass; dynamic; genetic; outcome

References

  1. J Cardiovasc Med (Hagerstown). 2016 Jan;17(1):54-61 - PubMed
  2. Thromb Haemost. 1998 Aug;80(2):220-4 - PubMed
  3. Hematol Pathol. 1994;8(1-2):35-42 - PubMed
  4. Ann Thorac Surg. 2007 Sep;84(3):823-8 - PubMed
  5. Lancet. 2013 Feb 23;381(9867):629-38 - PubMed
  6. Eur J Cardiothorac Surg. 2012 Sep;42(3):507-12 - PubMed
  7. J Am Coll Cardiol. 2013 Feb 26;61(8):808-16 - PubMed
  8. Inflammation. 2012 Apr;35(2):429-35 - PubMed
  9. Br J Haematol. 1997 Nov;99(2):262-7 - PubMed
  10. Ann Thorac Surg. 1998 Nov;66(5 Suppl):S12-6; discussion S25-8 - PubMed
  11. Am J Cardiol. 2001 Nov 15;88(10):1125-8 - PubMed
  12. Circulation. 2011 Dec 6;124(23):e652-735 - PubMed
  13. Transfusion. 2008 Oct;48(10):2152-8 - PubMed
  14. J Thorac Cardiovasc Surg. 2011 Oct;142(4):816-22 - PubMed
  15. Transfusion. 2013 Jun;53(6):1226-34 - PubMed
  16. Crit Care Med. 2005 Feb;33(2):355-60 - PubMed
  17. Chest. 2002 Jul;122(1):31-6 - PubMed
  18. Arch Med Res. 2011 Jul;42(5):375-81 - PubMed
  19. Am J Cardiol. 2006 Jun 15;97(12):1697-701 - PubMed
  20. Thorac Cardiovasc Surg. 2006 Jun;54(4):233-8 - PubMed
  21. Arterioscler Thromb Vasc Biol. 2003 Nov 1;23 (11):2063-9 - PubMed
  22. Ann Clin Biochem. 2010 Jul;47(Pt 4):343-9 - PubMed
  23. J Thorac Cardiovasc Surg. 2014 Aug;148(2):515-520.e2 - PubMed
  24. Circulation. 2006 Jul 4;114(1 Suppl):I275-81 - PubMed
  25. J Thorac Cardiovasc Surg. 2010 Feb;139(2):483-8, 488.e1-2 - PubMed
  26. Eur Heart J. 2010 Oct;31(20):2501-55 - PubMed
  27. Ann Thorac Surg. 2003 Dec;76(6):2007-12 - PubMed
  28. Circulation. 2010 Sep 14;122(11 Suppl):S60-5 - PubMed
  29. J Thorac Cardiovasc Surg. 2012 Feb;143(2):273-81 - PubMed
  30. J Thromb Haemost. 2005 Jun;3(6):1206-12 - PubMed
  31. Thromb Haemost. 2005 Jun;93(6):1101-7 - PubMed
  32. Heart Surg Forum. 2005;8(5):E373-7 - PubMed
  33. Atherosclerosis. 2009 May;204(1):196-201 - PubMed
  34. Circ J. 2009 May;73(5):872-7 - PubMed
  35. Ann Thorac Surg. 2006 Dec;82(6):2170-8 - PubMed
  36. Exp Ther Med. 2014 Jun;7(6):1721-1727 - PubMed
  37. J Thromb Thrombolysis. 2009 Jan;27(1):105-14 - PubMed
  38. Circulation. 1998 Mar 10;97(9):916-31 - PubMed
  39. J Card Surg. 2006 Sep-Oct;21(5):521-2 - PubMed
  40. Am Heart J. 1994 Feb;127(2):282-6 - PubMed
  41. Hum Genomics. 2010 Aug;4(6):375-83 - PubMed
  42. Thromb Haemost. 1994 Sep;72(3):335-42 - PubMed
  43. Anesthesiology. 2010 Mar;112(3):607-13 - PubMed
  44. J Thorac Cardiovasc Surg. 2003 Feb;125(2):336-43 - PubMed
  45. N Engl J Med. 2012 Dec 20;367(25):2375-84 - PubMed
  46. J Thorac Cardiovasc Surg. 2009 Oct;138(4):954-8 - PubMed
  47. N Engl J Med. 2012 Apr 19;366(16):1467-76 - PubMed
  48. JAMA. 2011 Jan 26;305(4):381-90 - PubMed
  49. Eur J Cardiothorac Surg. 2003 Aug;24(2):260-9 - PubMed
  50. J Cardiothorac Surg. 2011 Sep 28;6:120 - PubMed
  51. Eur J Cardiothorac Surg. 2011 Jul;40(1):e50-4 - PubMed
  52. J Thorac Cardiovasc Surg. 2005 Aug;130(2):303-8 - PubMed
  53. Thromb Res. 2000 Apr 1;98(1):39-49 - PubMed
  54. Ann Thorac Surg. 2004 Nov;78(5):1547-54 - PubMed
  55. Int J Cardiol. 2005 Jan;98(1):133-9 - PubMed
  56. Am J Med. 2003 Dec 1;115(8):660-3 - PubMed
  57. Circulation. 2011 Sep 13;124(11 Suppl):S143-8 - PubMed
  58. Int J Cardiol. 2007 Aug 9;120(1):108-14 - PubMed
  59. BMC Med Genet. 2009 May 08;10:38 - PubMed

Publication Types